| Benzothiazole derivatives as anticancer agents A Irfan, F Batool, SA Zahra Naqvi, A Islam, SM Osman, A Nocentini, ... Journal of enzyme inhibition and medicinal chemistry 35 (1), 265-279, 2020 | 232 | 2020 |
| Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018) A Nocentini, CT Supuran Expert Opinion on Therapeutic Patents 28 (10), 729-740, 2018 | 204 | 2018 |
| Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery A Nocentini, CT Supuran Expert Opinion on Drug Discovery 14 (11), 1175-1197, 2019 | 154 | 2019 |
| Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment A Angeli, F Carta, A Nocentini, JY Winum, R Zalubovskis, A Akdemir, ... Metabolites 10 (10), 412, 2020 | 137 | 2020 |
| Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene) thiazolidin-2-ylidene) amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and … WM Eldehna, MF Abo-Ashour, A Nocentini, P Gratteri, IH Eissa, M Fares, ... European journal of medicinal chemistry 139, 250-262, 2017 | 131 | 2017 |
| Benzoxaborole compounds for therapeutic uses: a patent review (2010-2018) A Nocentini, CT Supuran, JY Winum Expert opinion on therapeutic patents 28 (6), 493-504, 2018 | 122 | 2018 |
| Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and … A Nocentini, M Ferraroni, F Carta, M Ceruso, P Gratteri, C Lanzi, E Masini, ... Journal of Medicinal Chemistry 59 (23), 10692-10704, 2016 | 102 | 2016 |
| Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii S Del Prete, A Nocentini, CT Supuran, C Capasso Journal of Enzyme Inhibition and Medicinal Chemistry 35 (1), 1060-1068, 2020 | 101 | 2020 |
| Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase A Nocentini, A Angeli, F Carta, JY Winum, R Zalubovskis, S Carradori, ... Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 561-580, 2021 | 100 | 2021 |
| An overview on the recently discovered iota-carbonic anhydrases A Nocentini, CT Supuran, C Capasso Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1988-1995, 2021 | 93 | 2021 |
| Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC … WM Eldehna, MF Abo-Ashour, A Nocentini, RS El-Haggar, S Bua, ... European journal of medicinal chemistry 162, 147-160, 2019 | 93 | 2019 |
| Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand/isoform matching and selectivity of action A Bonardi, A Nocentini, S Bua, J Combs, C Lomelino, J Andring, ... Journal of medicinal chemistry 63 (13), 7422-7444, 2020 | 91 | 2020 |
| Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII A Nocentini, F Carta, M Ceruso, G Bartolucci, CT Supuran Bioorganic & Medicinal Chemistry 23 (21), 6955-6966, 2015 | 91 | 2015 |
| Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms A Nocentini, A Bonardi, P Gratteri, B Cerra, A Gioiello, CT Supuran Journal of Enzyme Inhibition and Medicinal Chemistry 33 (1), 1453-1459, 2018 | 87 | 2018 |
| Continued exploration of 1, 2, 4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX … M Krasavin, A Shetnev, T Sharonova, S Baykov, S Kalinin, A Nocentini, ... European Journal of Medicinal Chemistry 164, 92-105, 2019 | 82 | 2019 |
| 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico … MF Abo-Ashour, WM Eldehna, A Nocentini, A Bonardi, S Bua, HS Ibrahim, ... European Journal of Medicinal Chemistry 184, 111768, 2019 | 80 | 2019 |
| A new kid on the block? Carbonic anhydrases as possible new targets in Alzheimer’s disease G Provensi, F Carta, A Nocentini, CT Supuran, F Casamenti, MB Passani, ... International journal of molecular sciences 20 (19), 4724, 2019 | 80 | 2019 |
| Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer WM Eldehna, A Nocentini, ST Al-Rashood, GS Hassan, HM Alkahtani, ... Bioorganic Chemistry 81, 425-432, 2018 | 74 | 2018 |
| Selenols: A new class of carbonic anhydrase inhibitors A Angeli, D Tanini, A Nocentini, A Capperucci, M Ferraroni, P Gratteri, ... Chemical Communications 55 (5), 648-651, 2019 | 73 | 2019 |
| Structure–Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae CS Hewitt, NS Abutaleb, AEM Elhassanny, A Nocentini, X Cao, DP Amos, ... ACS infectious diseases 7 (7), 1969-1984, 2021 | 70 | 2021 |
Claudiu T. SupuranUniversity of Florence, Neurofabra DeptAdresse e-mail validée de unifi.it
